Literature DB >> 1933618

Use of calcitonin in the treatment of bone pain associated with osteoporosis.

C Gennari1, D Agnusdei, A Camporeale.   

Abstract

In osteoporosis, calcitonin exerts an analgesic effect that is unrelated to its effect on bone. Although the precise mechanism has yet to be clarified, there is some evidence that the analgesic effect of calcitonin may be mediated through the endogenous opioid system. The intranasal administration of calcitonin seems to be more effective in producing analgesia than parenteral administration.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1933618     DOI: 10.1007/bf02561370

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  8 in total

1.  Calcitonin gene-related peptide and its binding sites in the human central nervous system and pituitary.

Authors:  F A Tschopp; H Henke; J B Petermann; P H Tobler; R Janzer; T Hökfelt; J M Lundberg; C Cuello; J A Fischer
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

2.  [Calcitonin in acute pain due to vertebral fracture in osteoporosis. Cooperative study].

Authors:  R Arinoviche; M Arriagada; S Jacobelli; L Massardo; S Rivero; H Aris; M Valenzuela; C Rojas; A Carvallo; H Gatica
Journal:  Rev Med Chil       Date:  1987-11       Impact factor: 0.553

3.  Migraine prophylaxis with salmon calcitonin: a cross-over double-blind, placebo-controlled study.

Authors:  C Gennari; M S Chierichetti; S Gonnelli; C Vibelli; M Montagnani; M Piolini
Journal:  Headache       Date:  1986-01       Impact factor: 5.887

Review 4.  Pain mechanisms: a new theory.

Authors:  R Melzack; P D Wall
Journal:  Science       Date:  1965-11-19       Impact factor: 47.728

5.  [Treatment of ordinary osteoporosis by the combination of salmon calcitonin-phosphorus and magnesium].

Authors:  P Bordier; D Kuntz; L Miravet; P Marie
Journal:  Nouv Presse Med       Date:  1979-02-03

6.  Salmon calcitonin in the therapy of corticoid-induced osteoporosis.

Authors:  J D Ringe; D Welzel
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

7.  Calcitonin induced increase in ACTH, beta-endorphin and cortisol secretion.

Authors:  L Laurian; Z Oberman; E Graf; S Gilad; E Hoerer; R Simantov
Journal:  Horm Metab Res       Date:  1986-04       Impact factor: 2.936

8.  Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures.

Authors:  K K Pun; L W Chan
Journal:  Clin Ther       Date:  1989 Mar-Apr       Impact factor: 3.393

  8 in total
  18 in total

1.  Rheumatology: 15. Osteoporosis.

Authors:  J P Wade
Journal:  CMAJ       Date:  2001-07-10       Impact factor: 8.262

2.  Comparison of the analgesic efficacy of pamidronate and synthetic human calcitonin in osteoporotic vertebral fractures: a double-blind controlled study.

Authors:  M Laroche; S Cantogrel; B Jamard; A Constantin; L Zabraniecki; A Cantagrel; B Mazières
Journal:  Clin Rheumatol       Date:  2006-01-04       Impact factor: 2.980

Review 3.  Calcitonin for treating acute pain of osteoporotic vertebral compression fractures: a systematic review of randomized, controlled trials.

Authors:  Jennifer A Knopp; Barry M Diner; Maurice Blitz; George P Lyritis; Brian H Rowe
Journal:  Osteoporos Int       Date:  2004-12-22       Impact factor: 4.507

Review 4.  Calcitonin in the treatment of osteoporosis.

Authors:  C Gennari; A Camporeale
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

Review 5.  Calcitonin for treating acute and chronic pain of recent and remote osteoporotic vertebral compression fractures: a systematic review and meta-analysis.

Authors:  J A Knopp-Sihota; C V Newburn-Cook; J Homik; G G Cummings; D Voaklander
Journal:  Osteoporos Int       Date:  2011-06-10       Impact factor: 4.507

6.  The near absence of osteoporosis treatment in older men with fractures.

Authors:  Adrianne C Feldstein; Gregory Nichols; Eric Orwoll; Patricia J Elmer; David H Smith; Michael Herson; Mikel Aickin
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

7.  25 years of salmon calcitonin: from synthesis to therapeutic use.

Authors:  M Azria; D H Copp; J M Zanelli
Journal:  Calcif Tissue Int       Date:  1995-12       Impact factor: 4.333

Review 8.  Osteoporosis in women with breast cancer.

Authors:  Betty A Mincey
Journal:  Curr Oncol Rep       Date:  2003-01       Impact factor: 5.075

9.  Rectal salmon calcitonin for the treatment of postmenopausal osteoporosis.

Authors:  K Overgaard; M A Hansen; K L Dirksen; C Christiansen
Journal:  Calcif Tissue Int       Date:  1992-09       Impact factor: 4.333

10.  Long- and short-term side effects and safety of calcitonin in man: a prospective study.

Authors:  S J Wimalawansa
Journal:  Calcif Tissue Int       Date:  1993-02       Impact factor: 4.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.